Related Experiment Video

Updated: Mar 12, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.6K

SALL4 promotes gastric cancer progression through activating CD44 expression

X Yuan1, X Zhang1, W Zhang1

  • 1Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Jiangsu, China.

Oncogenesis
|November 8, 2016
PubMed

Insights

Stem cell factor SALL4 promotes gastric cancer by activating CD44. Inhibiting SALL4 or CD44 may offer new therapeutic strategies for gastric cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Stem cell factor SALL4 (Sal-like protein 4) is implicated in cancer development, including tumor growth, metastasis, and therapy resistance.
  • The precise mechanisms underlying SALL4's oncogenic functions, particularly in gastric cancer, remain incompletely understood.

Purpose of the Study:

  • To elucidate the role of SALL4 in gastric cancer progression.
  • To investigate the molecular mechanisms by which SALL4 drives gastric cancer growth and metastasis.
  • To identify potential therapeutic targets for gastric cancer based on SALL4-mediated pathways.

Main Methods:

  • Utilized short hairpin RNA (shRNA) and a tetracycline-inducible system to knockdown SALL4 expression in gastric cancer cells.
  • Assessed the impact of SALL4 knockdown on cell proliferation, migration, and invasion in vitro.
  • Performed luciferase assays and chromatin immunoprecipitation (ChIP) to determine SALL4's interaction with the CD44 promoter.
  • Conducted rescue experiments with CD44 overexpression to validate the findings in vitro and in vivo.

Main Results:

  • SALL4 knockdown significantly inhibited gastric cancer cell proliferation, migration, and invasion.
  • SALL4 was found to directly bind to the CD44 promoter region, transcriptionally activating its expression.
  • Overexpression of CD44 counteracted the inhibitory effects of SALL4 knockdown on gastric cancer cell behavior and tumor growth.
  • Gastric cancer progression was linked to SALL4-driven CD44 upregulation.

Conclusions:

  • SALL4 promotes gastric cancer progression by directly activating CD44 expression.
  • The SALL4-CD44 axis represents a novel mechanism contributing to the oncogenic roles of SALL4 in gastric cancer.
  • Targeting the SALL4-CD44 pathway offers a promising new therapeutic strategy for gastric cancer treatment.

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K
A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells06:38

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells

Published on: January 22, 2021

7.0K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K